Loading
Latest filing published 21 Sept 2026 for Pharvaris N.V., €9.2M.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Berndt Modig is a declared insider at 2 companies; the most frequent names are Pharvaris N.V. and Sio Gene Therapies Inc. Over a trading history stretching from 29 December 2017 to 17 September 2026, the count stands at 8 filings.
No open-market purchase appears, only 6 sales worth €827k. The rest of the record consists of 2 option exercises. 2026 to date brings no purchases and 6 sales.
The newest entry dates from 21 September 2026: an option exercise of €9.2M, in Pharvaris N.V. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations